Double Medical Technology Inc. (SHE:002901)
China
· Delayed Price · Currency is CNY 57.51
-4.33 (-7.00%)
Aug 14, 2025, 2:45 PM CST
Double Medical Technology Revenue
Double Medical Technology had revenue of 550.34M CNY in the quarter ending March 31, 2025, with 28.80% growth. This brings the company's revenue in the last twelve months to 2.26B, up 43.95% year-over-year. In the year 2024, Double Medical Technology had annual revenue of 2.14B with 39.29% growth.
Revenue (ttm)
2.26B
Revenue Growth
+43.95%
P/S Ratio
10.31
Revenue / Employee
501.58K
Employees
4,503
Market Cap
23.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.14B | 602.44M | 39.29% |
| Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
| Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
| Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
| Dec 31, 2020 | 1.59B | 329.54M | 26.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| WuXi AppTec | 41.48B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |